Drug Profile
VN D301
Alternative Names: VN-D301Latest Information Update: 28 Mar 2021
Price :
$50
*
At a glance
- Originator VitNovo
- Class Diagnostic agents
- Mechanism of Action Diagnostic imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Mar 2021 No recent reports of development identified for research development in Unspecified in Taiwan
- 28 Mar 2021 No recent reports of development identified for research development in Unspecified(Diagnosis) in Taiwan
- 07 Feb 2017 Early research in Undefined indication (Diagnosis) in Taiwan (unspecified route)